{"id":"https://openalex.org/W2170318356","doi":"https://doi.org/10.1002/dta.1803","title":"Comparison of urine analysis and dried blood spot analysis for the detection of ephedrine and methylephedrine in doping control","display_name":"Comparison of urine analysis and dried blood spot analysis for the detection of ephedrine and methylephedrine in doping control","publication_year":2015,"publication_date":"2015-04-13","ids":{"openalex":"https://openalex.org/W2170318356","doi":"https://doi.org/10.1002/dta.1803","mag":"2170318356","pmid":"https://pubmed.ncbi.nlm.nih.gov/25869885"},"language":"en","primary_location":{"id":"doi:10.1002/dta.1803","doi":"https://doi.org/10.1002/dta.1803","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.1803","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109105641","display_name":"Asami Kojima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265362","display_name":"LSI Medience Corporation (Japan)","ror":"https://ror.org/04k75jj88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265362"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Asami Kojima","raw_affiliation_strings":["Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan","institution_ids":["https://openalex.org/I4405265362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002408354","display_name":"Yasunori Nishitani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265362","display_name":"LSI Medience Corporation (Japan)","ror":"https://ror.org/04k75jj88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265362"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunori Nishitani","raw_affiliation_strings":["Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan","institution_ids":["https://openalex.org/I4405265362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047255574","display_name":"Mitsuhiko P. Sato","orcid":"https://orcid.org/0000-0001-5383-5499","observed_orcids":["https://orcid.org/0000-0001-5383-5499"]},"institutions":[{"id":"https://openalex.org/I4405265362","display_name":"LSI Medience Corporation (Japan)","ror":"https://ror.org/04k75jj88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265362"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuhiko Sato","raw_affiliation_strings":["Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan","institution_ids":["https://openalex.org/I4405265362"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shinji Kageyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265362","display_name":"LSI Medience Corporation (Japan)","ror":"https://ror.org/04k75jj88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265362"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinji Kageyama","raw_affiliation_strings":["Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan","institution_ids":["https://openalex.org/I4405265362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051876397","display_name":"Michiko Dohi","orcid":"https://orcid.org/0000-0002-1126-7849","observed_orcids":["https://orcid.org/0000-0002-1126-7849"]},"institutions":[{"id":"https://openalex.org/I4405287692","display_name":"Japan Institute of Sports Sciences","ror":"https://ror.org/05xemht68","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210109266","https://openalex.org/I4405287692"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michiko Dohi","raw_affiliation_strings":["Medical Centre Japan Institute of Sports Sciences Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Centre Japan Institute of Sports Sciences Tokyo Japan","institution_ids":["https://openalex.org/I4405287692"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064882300","display_name":"Masato Okano","orcid":"https://orcid.org/0000-0003-3614-4121","observed_orcids":["https://orcid.org/0000-0003-3614-4121"]},"institutions":[{"id":"https://openalex.org/I4405265362","display_name":"LSI Medience Corporation (Japan)","ror":"https://ror.org/04k75jj88","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405265362"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masato Okano","raw_affiliation_strings":["Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anti-Doping Laboratory LSI Medience Corporation Tokyo Japan","institution_ids":["https://openalex.org/I4405265362"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064882300"],"corresponding_institution_ids":["https://openalex.org/I4405265362"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":null,"fwci":6.8963,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.9584431,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"8","issue":"2","first_page":"189","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12700","display_name":"Doping in Sports","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3312","display_name":"Sociology and Political Science"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12700","display_name":"Doping in Sports","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3312","display_name":"Sociology and Political Science"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13338","display_name":"Pharmacological Effects and Assays","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ephedrine","display_name":"ephedrine","score":1.0},{"id":"https://openalex.org/keywords/methylephedrine","display_name":"methylephedrine","score":1.0},{"id":"https://openalex.org/keywords/doping-control","display_name":"doping control","score":0.7139999866485596},{"id":"https://openalex.org/keywords/dried-blood-spots","display_name":"dried blood spots","score":0.5630000233650208},{"id":"https://openalex.org/keywords/urine-analysis","display_name":"urine analysis","score":0.7919999957084656},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.44600000977516174},{"id":"https://openalex.org/keywords/blood-levels","display_name":"blood concentration","score":0.5019999742507935},{"id":"https://openalex.org/keywords/urine-ph","display_name":"urine pH","score":0.7070000171661377},{"id":"https://openalex.org/keywords/urine-output","display_name":"urine output","score":0.925000011920929},{"id":"https://openalex.org/keywords/liquid-chromatography-tandem-mass-spectrometry","display_name":"liquid chromatography-tandem mass spectrometry","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2778984665","wikidata":"https://www.wikidata.org/wiki/Q219626","display_name":"Ephedrine","level":2,"score":0.9241993427276611},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.6770808696746826},{"id":"https://openalex.org/C2776597655","wikidata":"https://www.wikidata.org/wiki/Q5307389","display_name":"Dried blood spot","level":2,"score":0.4122840166091919},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4078959822654724},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.38691410422325134},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32751893997192383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24064090847969055},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.22110092639923096}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":true},{"descriptor_ui":"D002138","descriptor_name":"Calibration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004300","descriptor_name":"Doping in Sports","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004809","descriptor_name":"Ephedrine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004809","descriptor_name":"Ephedrine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004809","descriptor_name":"Ephedrine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015813","descriptor_name":"Substance Abuse Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016482","descriptor_name":"Urinalysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059788","descriptor_name":"Dried Blood Spot Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/dta.1803","doi":"https://doi.org/10.1002/dta.1803","is_oa":false,"landing_page_url":"https://doi.org/10.1002/dta.1803","pdf_url":null,"source":{"id":"https://openalex.org/S36361591","display_name":"Drug Testing and Analysis","issn_l":"1942-7603","issn":["1942-7603","1942-7611"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Testing and Analysis","raw_type":"journal-article"},{"id":"pmid:25869885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25869885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug testing and analysis","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317195","display_name":"Nichi-Iko Pharmaceutical","ror":"https://ror.org/02rnfc528"},{"id":"https://openalex.org/F4320321049","display_name":"World Anti-Doping Agency","ror":"https://ror.org/00v3jqn19"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1492040595","https://openalex.org/W1505822668","https://openalex.org/W1528398670","https://openalex.org/W1972677208","https://openalex.org/W1976606909","https://openalex.org/W1981643076","https://openalex.org/W1983257657","https://openalex.org/W1989933530","https://openalex.org/W2002883043","https://openalex.org/W2003162418","https://openalex.org/W2010222138","https://openalex.org/W2011602524","https://openalex.org/W2023592301","https://openalex.org/W2024773741","https://openalex.org/W2037157395","https://openalex.org/W2044354502","https://openalex.org/W2046528100","https://openalex.org/W2057627287","https://openalex.org/W2064320659","https://openalex.org/W2065967572","https://openalex.org/W2071044508","https://openalex.org/W2112438562","https://openalex.org/W2113051108","https://openalex.org/W2120399252","https://openalex.org/W2121378765","https://openalex.org/W2124854669","https://openalex.org/W2127925653","https://openalex.org/W2135881050","https://openalex.org/W2140889316","https://openalex.org/W2143416773","https://openalex.org/W2153623068","https://openalex.org/W2154329081","https://openalex.org/W2156047110","https://openalex.org/W2156212474","https://openalex.org/W2156993555","https://openalex.org/W2159548316","https://openalex.org/W2168021129","https://openalex.org/W2172120814","https://openalex.org/W2228626224","https://openalex.org/W4211099940"],"related_works":["https://openalex.org/W4283388489","https://openalex.org/W2062839828","https://openalex.org/W2140889316","https://openalex.org/W1965763541","https://openalex.org/W2137351109","https://openalex.org/W2464582143","https://openalex.org/W2044354502","https://openalex.org/W2102826290","https://openalex.org/W2972716372","https://openalex.org/W1982515221"],"abstract_inverted_index":{"When":[0],"the":[1,13,22,25,34,46,55,65,68,100,108,117,123,132,137,142,154,166,191,195,220,235],"misuse":[2],"of":[3,24,58,70,98,103,135,169,198,223,238],"stimulants":[4,239],"is":[5],"determined":[6],"in":[7,113,121,161,225],"doping":[8],"control":[9],"tests":[10],"conducted":[11],"during":[12,240],"in-competition":[14,241],"period,":[15],"athletes":[16],"are":[17],"asked":[18],"to":[19,31,82,90,140,146],"account":[20],"for":[21,40,144,234],"violation":[23],"rules.":[26],"This":[27],"study":[28,66],"was":[29,119],"designed":[30],"evaluate":[32],"whether":[33],"urinary":[35,101,133,196,216],"threshold":[36,109,118,143,155],"values":[37],"(10":[38],"\u00b5g/mL)":[39],"ephedrine":[41,84,104,170,199],"and":[42,85,171,190,200],"methylephedrine":[43,86,172,201],"set":[44],"by":[45,87,206],"World":[47],"Anti-Doping":[48],"Agency":[49],"(WADA)":[50],"can":[51,202],"be":[52,203,232],"exceeded":[53,120],"after":[54,128,149,159,180],"oral":[56],"administration":[57,97,160],"each":[59],"substance":[60],"(25":[61],"mg).":[62],"In":[63,164],"addition,":[64],"describes":[67],"validity":[69],"a":[71,91,186],"liquid":[72],"chromatography-tandem":[73],"mass":[74],"spectrometric":[75],"method":[76],"using":[77],"dried":[78,228],"blood":[79,167,183,229],"spot":[80],"testing":[81],"detect":[83],"comparing":[88],"it":[89],"quantitative":[92],"laboratory":[93],"urine":[94,207,210],"assay.":[95],"After":[96],"ephedrine,":[99],"concentration":[102],"did":[105],"not":[106],"exceed":[107],"at":[110,125,156,177],"4-10":[111],"h":[112,127,148,158,179],"two":[114],"subjects,":[115],"whereas":[116],"both":[122],"subjects":[124,138],"12":[126],"administration.":[129,150,181],"For":[130],"methylephedrine,":[131],"concentrations":[134,152,168,184,217],"all":[136],"failed":[139],"reach":[141],"up":[145],"10":[147],"The":[151,182],"reached":[153,173],"12-24":[157],"some":[162],"volunteers.":[163],"contrast,":[165],"their":[174],"maximum":[175],"levels":[176],"2-8":[178],"showed":[185],"low":[187],"inter-individual":[188],"variability,":[189],"results":[192],"suggested":[193],"that":[194,215],"excretion":[197],"strongly":[204],"affected":[205],"pH":[208],"and/or":[209],"volume.":[211],"These":[212],"facts":[213],"suggest":[214],"cannot":[218],"reflect":[219],"psychoactive":[221],"level":[222],"ephedrines":[224],"circulation.":[226],"Thus,":[227],"analysis":[230],"might":[231],"suitable":[233],"adequate":[236],"detection":[237],"testing.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}